Together, these two studies validated HIF2α [78] and HIF2 [79] as PT2399’s target, respectively, in human ccRCC even though some ccRCCs are HIF2 independent [79]. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.